View the event
| Reference: | 3331 |
| Country: | Denmark |
| Multiple country event: | No |
| Region: | EURO |
| City: | Copenhagen |
| Start date: | 25 March 2011 |
| End date: | 8 April 2011 |
| Estimated duration: | |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | Soliciting suggestions and inputs on consolidated Plan to Prevent and Combat M/XDR TB |
| Type: | Conference (open - ouvert) |
| Terms of Reference: | In response to the alarming problem of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in the Europe, the Regional Director of WHO/Europe has established a Special Project to Prevent and Combat M/XDR-TB in the Region. In order to scale up the comprehensive response and prevent and control M/XDR-TB, a Consolidated Action Plan is being developed for 2011 to 2015, to function as a road map for Member States, WHO/Europe and partners.
The targets and objectives of the Consolidated Action Plan to Prevent and Combat M/XDR-TB in the WHO European Region are aligned with those of the MDR-TB section of the Global Plan to Stop TB, 2011-2015 and the World Health Assembly Resolution 62.15 urging all Member States to achieve universal access to diagnosis and treatment of MDR-TB by 2015. The Consolidated Action Plan to Prevent and Combat M/XDR-TB, 2011-2015 is built upon the core principles of the Health2020 Strategy with the vision of equitable access to health.
The Plan is being prepared in region-wide consultation with experts, patients and communities suffering from the disease. The draft Plan has been sent to Member States for consultation. Our partner organization, Europe TB Coalition has posted the Plan on their website for consultation with the civil society organizations, communities and experts across the Region (www.tbcoalition.eu).
The Consolidated Action Plan to Prevent and Combat M/XDR-TB, 2011-2015 will be submitted for endorsement by the WHO Regional Committee for Europe in Baku, Azerbaijan, in September 2011 along with an accompanying resolution.
|
| Training Opportunity: | No |
| Website: | http://discussion.euro.who.int/forum/topic/listForContributor?user=37fqdpb3karyv&sort=discussionsStarted&page=1 |
| Purpose 1: | MDR-TB / XDR-TB |
| Purpose 2: | |
| Purpose 3: | |
| Other purpose: | |
|
| Entered by: | WHO/EURO |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Dr Ogtay Gozalov |
| Contact email: | ogo@euro.who.int |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | Eli Lilly MDR Partnership |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | We would like to invite you to participate in the discussions and provide your views via WHO/Europe webpage Public Health Forum (http://discussion.euro.who.int/forum/topics/soliciting-suggestions-and). |
| |
There are no experts (non-roster) associated with this event.
Date Created: 25 March 2011
Entered By: Europe Office (WHO)
|
